Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-&gamma;

doi:10.3748/wjg.v12.i19.3006

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3101)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

314

HTML

2574

Figures (1-6)

213

Sum=3101

May 21, 2006 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. May 21, 2006; 12(19): 3006-3014
Published online May 21, 2006. doi: 10.3748/wjg.v12.i19.3006

Full Size Figure Download Figure

Figure 6 Effect of sequential treatment with “high-dose” of Lamivudine and IFN-γon HBV cccDNA pool in transduced HepG2 cells. The figure shows densitometric analysis of the 2 kb cccDNA form. 1: Untreated control; 2: Lamivudine (0.2 μmol/L) 8 d; 3: Lamivudine (0.2 μmol/L) 2 d + IFN-γ (5.0 μg/L) 6 d.

Citation: Parvez MK, Sehgal D, Sarin SK, Basir SF, Jameel S. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-γ. World J Gastroenterol 2006; 12(19): 3006-3014
URL: https://www.wjgnet.com/1007-9327/full/v12/i19/3006.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i19.3006